Completed PHASE4 INTERVENTIONAL 2-arm NCT02234492

The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients

Sponsor: Ontario HIV Treatment Network

Conditions Cardiovascular Disease (CVD) Human Immunodeficiency Virus (HIV)

Updated 6 times since 2017 Last updated: Oct 3, 2018 Started: Sep 30, 2014 Primary completion: Oct 31, 2018 Completion: Oct 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02234492, this PHASE4 trial focuses on Cardiovascular Disease (CVD) and Human Immunodeficiency Virus (HIV) and remains completed. Sponsored by Ontario HIV Treatment Network, it has been updated 6 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Nov 2018 — Jan 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Jun 2018 — Nov 2018 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ontario HIV Treatment Network
Ottawa Heart Institute Research Corporation

Data source: Ottawa Heart Institute Research Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ottawa, Canada